Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...

Dow Jones Industrial Average sheds 200 points as Treasury yields rise

The Dow Jones Industrial Average fell back from the 48,000 handle on Monday as investor expectations for an upcoming interest ...

The new rules of visibility in an AI-led search world

Something strange is happening in the world of digital search. Australian brands are reporting a fall in organic traffic for ...